郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.

期刊：British journal of pharmacology发表年份：2009作者：J-C Martel; M-B Assié; L Bardin; R Depoortère; D Cussac; A Newman-Tancredi
阅读更多 →

药效评价Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2009作者：Lawrence Toll; Taline V Khroyan; Willma E Polgar; Faming Jiang; Cris Olsen; Nurulain T Zaveri
阅读更多 →

药效评价Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.

期刊：Naunyn-Schmiedeberg's archives of pharmacology发表年份：2009作者：Christopher S Knauer; Jeffrey E Campbell; Christopher L Chio; Lawrence W Fitzgerald
阅读更多 →

药效评价Preventive effect of 7,8-dihydroxyflavone against oxidative stress induced genotoxicity.

期刊：Biological & pharmaceutical bulletin发表年份：2009作者：Rui Zhang; Kyoung Ah Kang; Mei Jing Piao; Dong Ok Ko; Zhi Hong Wang; Weon Young Chang; Ho Jin You; In Kyung Lee; Bum Joon Kim; Sam Sik Kang; Jin Won Hyun
阅读更多 →